These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19833683)

  • 1. Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.
    Gounaris I; Ahmad A
    J Oncol Pharm Pract; 2010 Dec; 16(4):277-9. PubMed ID: 19833683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
    Santini D; Vincenzi B; Schiavon G; Di Seri M; Virzí V; Spalletta B; Caricato M; Coppola R; Tonini G
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):613-20. PubMed ID: 16944151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.
    Jackson CG; Sharples K; Thompson PI; O'Donnell A; Robinson BA; Perez DJ; Adams J; Isaacs R; Deva S; Hinder VA; Findlay MP
    BMC Cancer; 2014 Oct; 14():737. PubMed ID: 25274181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential regional differences for the tolerability profiles of fluoropyrimidines.
    Haller DG; Cassidy J; Clarke SJ; Cunningham D; Van Cutsem E; Hoff PM; Rothenberg ML; Saltz LB; Schmoll HJ; Allegra C; Bertino JR; Douillard JY; Gustavsson BG; Milano G; O'Connell M; Rustum Y; Tabernero J; Gilberg F; Sirzén F; Twelves C
    J Clin Oncol; 2008 May; 26(13):2118-23. PubMed ID: 18445840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
    Mohammed TA; Dennie T; Holen KD
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients.
    Van Cutsem E; Verslype C; Beale P; Clarke S; Bugat R; Rakhit A; Fettner SH; Brennscheidt U; Feyereislova A; Delord JP
    Ann Oncol; 2008 Feb; 19(2):332-9. PubMed ID: 17986625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.
    Chu E; Schulman KL; McKenna EF; Cartwright T
    Clin Colorectal Cancer; 2010 Oct; 9(4):229-37. PubMed ID: 20920995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
    Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ACT: an important step on an unfinished journey.
    Maughan T
    Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
    [No Abstract]   [Full Text] [Related]  

  • 10. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer.
    Dzaye O; Cleator S; Nihoyannopoulos P
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment.
    Orsucci D; Pizzanelli C; Alì G; Calabrese R; Ricci G; Lenzi P; Petrozzi L; Moretti P; Siciliano G
    Neuromuscul Disord; 2012 Aug; 22(8):767-70. PubMed ID: 22652078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
    Kim ST; Choi YJ; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2011 Mar; 7(1):82-7. PubMed ID: 21332655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].
    Zhao WY; Chen DY; Qi Q
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):295-8. PubMed ID: 21575503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
    Carrato A; Gallego-Plazas J; Guillén-Ponce C
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
    Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
    J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.
    Scheithauer W; Kornek GV; Raderer M; Schüll B; Schmid K; Längle F; Huber H
    Ann Oncol; 2002 Oct; 13(10):1583-9. PubMed ID: 12377646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].
    Zhao Y; An X; Xiang XJ; Feng F; Wang FH; Wang ZQ; Xu RH; He YJ; Li YH
    Chin J Cancer; 2010 Jan; 29(1):102-5. PubMed ID: 20038320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01.
    Hong YS; Jung KH; Kim HJ; Kim KP; Kim SY; Lee JL; Shim BY; Zang DY; Kim JH; Ahn JB; Park YS; Kim TW
    Am J Clin Oncol; 2013 Dec; 36(6):565-71. PubMed ID: 22868243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
    Shibata SI; Doroshow JH; Frankel P; Synold TW; Yen Y; Gandara DR; Lenz HJ; Chow WA; Leong LA; Lim D; Margolin KA; Morgan RJ; Somlo G; Newman EM
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1149-55. PubMed ID: 19322566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.